Eric K. Nakakura, MD, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Eric K. Nakakura, MD, PhD

Associate Professor, Department of Surgery, UCSF

Phone: (415) 353-9888 (appts)
Box 1932, UCSF
San Francisco, CA 94143-1932

View on UCSF Profiles

Cancer Center Membership

Associate Member ยป Non-aligned

Education

University of California, San Diego, La Jolla, CA, BS, 1990, Bioengineering-Premedic
Stanford Medical School, Stanford, CA, MD, 1995, Medicine
Johns Hopkins University, Baltimore, PhD, 2001, Cellular/Molecular Medicine


Professional Experience

  • 1995-1996
    Intern, General Surgery, Johns Hopkins Medical Institutions, Baltimore, MD
  • 1996-2003
    Resident, General Surgery, Johns Hopkins Medical Institutions, Baltimore, MD
  • 2003-2004
    Fellow, Surgical Oncology, Johns Hopkins Medical Institutions, Baltimore, MD
  • 2003-2004
    Assistant Chief of Service/Instructor, General Surgery, Johns Hopkins Medical Institutions
  • 2004-2011
    Assistant Professor, Department of Surgery, University of California, San Francisco
  • 2011-present
    Associate Professor, Department of Surgery, University of California, San Francisco

Honors & Awards

  • 1988
    Phi Beta Kappa, University of California, San Diego
  • 1990
    Magna Cum Laude, University of California, San Diego
  • 1991
    Stanford Medical Student Scholars Program Research Fellow
  • 1992
    International Society for Heart and Lung Transplantation Poster Award Recipient
  • 1992
    American Heart Association Medical Student Research Fellow
  • 2000
    George D. Zuidema Award for Laboratory Research, Department of Surgery, Johns Hopkins Medical Institutions
  • 2003
    John L. Cameron Technical Excellence Award, Department of Surgery, Johns Hopkins Medical Institutions
  • 2007
    Excellence in Teaching Award, Department of Surgery, University of California, San Francisco School of Medicine
  • 2009
    Excellence in Teaching Award, The Haile T. Debas Academy of Medical Educators
    Memberships

Selected Publications

  1. Correcting for respiratory motion in liver PET/MRI: preliminary evaluation of the utility of bellows and navigated hepatobiliary phase imaging. EJNMMI Phys. 2015 Dec; 2(1):21.
    View on PubMed
  2. Solid pseudopapillary neoplasm of the pancreas head in a pregnant woman: safe pancreaticoduodenectomy postpartum. J Surg Case Rep. 2015; 2015(8).
    View on PubMed
  3. Simultaneous (68)Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor. Abdom Imaging. 2015 Aug; 40(6):1432-40.
    View on PubMed
  4. A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer. J Gastrointest Oncol. 2014 Dec; 5(6):E88-95.
    View on PubMed
  5. Bone metastases and skeletal-related events from neuroendocrine tumors. Endocr Connect. 2015 Mar; 4(1):9-17.
    View on PubMed
  6. Neuroendocrine tumors of unknown primary: is the primary site really not known? JAMA Surg. 2014 Sep; 149(9):889-90.
    View on PubMed
  7. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2014 Aug; 12(8):1083-93.
    View on PubMed
  8. Time to put another surgical dogma to sleep? JAMA Surg. 2014 May; 149(5):466.
    View on PubMed
  9. Home, sweet home, after surgery. JAMA Surg. 2014 Mar; 149(3):251.
    View on PubMed
  10. Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors. Oncogene. 2014 Mar 20; 33(12):1590-600.
    View on PubMed
  11. Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver. Semin Oncol. 2013 Feb; 40(1):69-74.
    View on PubMed
  12. Reply to P.H. Sugarbaker. J Clin Oncol. 2013 Jan 20; 31(3):397-8.
    View on PubMed
  13. Can CT features differentiate between inferior vena cava leiomyosarcomas and primary retroperitoneal masses? AJR Am J Roentgenol. 2013 Jan; 200(1):205-9.
    View on PubMed
  14. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients. Pancreas. 2012 Aug; 41(6):840-4.
    View on PubMed
  15. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2012 Jun 1; 10(6):703-13.
    View on PubMed
  16. Pseudomyxoma peritonei: more questions than answers. J Clin Oncol. 2012 Jul 10; 30(20):2429-30.
    View on PubMed
  17. Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures. World J Surg Oncol. 2011; 9:143.
    View on PubMed
  18. Unique patterns of metastases in common and rare types of malignancy. J Surg Oncol. 2011 May 1; 103(6):607-14.
    View on PubMed
  19. Pancreatic adenocarcinoma. J Natl Compr Canc Netw. 2010 Sep; 8(9):972-1017.
    View on PubMed
  20. Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site. J Surg Res. 2010 Sep; 163(1):47-51.
    View on PubMed

Go to UCSF Profiles, powered by CTSI